Warm Autoimmune Hemolytic Anemia Market to Observe Stunning Growth at a 14.4% CAGR During the Forecast Period (2026-2036) Due to the Emergence of Novel Drug Classes Such as FcRn Inhibitors, BTK Inhibitors, BAFF-R, and Others | DelveInsight
The wAIHA market landscape is undergoing a significant evolution after years of dependence on broad immunosuppressive therapies such as corticosteroids, rituximab, and other nonspecific agents. Current pipeline developments are steering the market toward targeted, mechanism-based immune...
The wAIHA market landscape is undergoing a significant evolution after years of dependence on broad immunosuppressive therapies such as corticosteroids, rituximab, and other nonspecific agents. Current pipeline developments are steering the market toward targeted, mechanism-based immune...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.